Global Drug Eluting Stents (DES) Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Drug Eluting Stents (DES) market size was estimated at USD 1670.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug Eluting Stents (DES) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug Eluting Stents (DES) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Eluting Stents (DES) market.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Eluting Stents (DES) Market
Overview of the regional outlook of the Drug Eluting Stents (DES) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Eluting Stents (DES), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Drug Eluting Stents (DES) market size was estimated at USD 1670.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drug Eluting Stents (DES) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drug Eluting Stents (DES) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drug Eluting Stents (DES) market.
Global Drug Eluting Stents (DES) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market Segmentation (by Type)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market Segmentation (by Application)
Coronary Heart Disease
Clinical
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Drug Eluting Stents (DES) Market
Overview of the regional outlook of the Drug Eluting Stents (DES) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Eluting Stents (DES) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drug Eluting Stents (DES), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
1.2.1 Drug Eluting Stents (DES) Segment by Type
1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG ELUTING STENTS (DES) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG ELUTING STENTS (DES) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug Eluting Stents (DES) Product Life Cycle
3.3 Global Drug Eluting Stents (DES) Sales by Manufacturers (2020-2025)
3.4 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Drug Eluting Stents (DES) Market Competitive Situation and Trends
3.8.1 Drug Eluting Stents (DES) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUG ELUTING STENTS (DES) INDUSTRY CHAIN ANALYSIS
4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG ELUTING STENTS (DES) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drug Eluting Stents (DES) Market
5.7 ESG Ratings of Leading Companies
6 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
6.3 Global Drug Eluting Stents (DES) Market Size by Type (2020-2025)
6.4 Global Drug Eluting Stents (DES) Price by Type (2020-2025)
7 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2020-2025)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2020-2025)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
8 DRUG ELUTING STENTS (DES) MARKET SALES BY REGION
8.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 Global Drug Eluting Stents (DES) Market Size by Region
8.2.1 Global Drug Eluting Stents (DES) Market Size by Region
8.2.2 Global Drug Eluting Stents (DES) Market Size by Region
8.3 North America
8.3.1 North America Drug Eluting Stents (DES) Sales by Country
8.3.2 North America Drug Eluting Stents (DES) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug Eluting Stents (DES) Sales by Country
8.4.2 Europe Drug Eluting Stents (DES) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
8.5.2 Asia Pacific Drug Eluting Stents (DES) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug Eluting Stents (DES) Sales by Country
8.6.2 South America Drug Eluting Stents (DES) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
8.7.2 Middle East and Africa Drug Eluting Stents (DES) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUG ELUTING STENTS (DES) MARKET PRODUCTION BY REGION
9.1 Global Production of Drug Eluting Stents (DES) by Region(2020-2025)
9.2 Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
9.3 Global Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug Eluting Stents (DES) Production
9.4.1 North America Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.4.2 North America Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug Eluting Stents (DES) Production
9.5.1 Europe Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.5.2 Europe Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug Eluting Stents (DES) Production (2020-2025)
9.6.1 Japan Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.6.2 Japan Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug Eluting Stents (DES) Production (2020-2025)
9.7.1 China Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.7.2 China Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Vascular
10.1.1 Abbott Vascular Basic Information
10.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
10.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
10.1.4 Abbott Vascular Business Overview
10.1.5 Abbott Vascular SWOT Analysis
10.1.6 Abbott Vascular Recent Developments
10.2 Advantec Vascular
10.2.1 Advantec Vascular Basic Information
10.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
10.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
10.2.4 Advantec Vascular Business Overview
10.2.5 Advantec Vascular SWOT Analysis
10.2.6 Advantec Vascular Recent Developments
10.3 B.Braun Melsengen AG
10.3.1 B.Braun Melsengen AG Basic Information
10.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
10.3.4 B.Braun Melsengen AG Business Overview
10.3.5 B.Braun Melsengen AG SWOT Analysis
10.3.6 B.Braun Melsengen AG Recent Developments
10.4 Biosensors
10.4.1 Biosensors Basic Information
10.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
10.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
10.4.4 Biosensors Business Overview
10.4.5 Biosensors Recent Developments
10.5 Biotronik
10.5.1 Biotronik Basic Information
10.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
10.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
10.5.4 Biotronik Business Overview
10.5.5 Biotronik Recent Developments
10.6 Blue Medical
10.6.1 Blue Medical Basic Information
10.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
10.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
10.6.4 Blue Medical Business Overview
10.6.5 Blue Medical Recent Developments
10.7 Boston Scientific
10.7.1 Boston Scientific Basic Information
10.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
10.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
10.7.4 Boston Scientific Business Overview
10.7.5 Boston Scientific Recent Developments
10.8 DISA Vascular
10.8.1 DISA Vascular Basic Information
10.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
10.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
10.8.4 DISA Vascular Business Overview
10.8.5 DISA Vascular Recent Developments
10.9 Essen
10.9.1 Essen Basic Information
10.9.2 Essen Drug Eluting Stents (DES) Product Overview
10.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
10.9.4 Essen Business Overview
10.9.5 Essen Recent Developments
10.10 Medtronic Vascular
10.10.1 Medtronic Vascular Basic Information
10.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
10.10.4 Medtronic Vascular Business Overview
10.10.5 Medtronic Vascular Recent Developments
10.11 MicroPort Medical
10.11.1 MicroPort Medical Basic Information
10.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
10.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
10.11.4 MicroPort Medical Business Overview
10.11.5 MicroPort Medical Recent Developments
10.12 MIV Therapeutics
10.12.1 MIV Therapeutics Basic Information
10.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
10.12.4 MIV Therapeutics Business Overview
10.12.5 MIV Therapeutics Recent Developments
10.13 Orbusneich
10.13.1 Orbusneich Basic Information
10.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
10.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
10.13.4 Orbusneich Business Overview
10.13.5 Orbusneich Recent Developments
10.14 Promed Medical
10.14.1 Promed Medical Basic Information
10.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
10.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
10.14.4 Promed Medical Business Overview
10.14.5 Promed Medical Recent Developments
10.15 Relisys Medical
10.15.1 Relisys Medical Basic Information
10.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
10.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
10.15.4 Relisys Medical Business Overview
10.15.5 Relisys Medical Recent Developments
10.16 Reva Medical
10.16.1 Reva Medical Basic Information
10.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
10.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
10.16.4 Reva Medical Business Overview
10.16.5 Reva Medical Recent Developments
10.17 Sahajanand
10.17.1 Sahajanand Basic Information
10.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
10.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
10.17.4 Sahajanand Business Overview
10.17.5 Sahajanand Recent Developments
10.18 Sino Medical
10.18.1 Sino Medical Basic Information
10.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
10.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
10.18.4 Sino Medical Business Overview
10.18.5 Sino Medical Recent Developments
10.19 Sorin
10.19.1 Sorin Basic Information
10.19.2 Sorin Drug Eluting Stents (DES) Product Overview
10.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
10.19.4 Sorin Business Overview
10.19.5 Sorin Recent Developments
10.20 Terumo Medical
10.20.1 Terumo Medical Basic Information
10.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
10.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
10.20.4 Terumo Medical Business Overview
10.20.5 Terumo Medical Recent Developments
11 DRUG ELUTING STENTS (DES) MARKET FORECAST BY REGION
11.1 Global Drug Eluting Stents (DES) Market Size Forecast
11.2 Global Drug Eluting Stents (DES) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
11.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug Eluting Stents (DES) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2026-2035)
12.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2026-2035)
12.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2026-2035)
12.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
12.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Eluting Stents (DES)
1.2 Key Market Segments
1.2.1 Drug Eluting Stents (DES) Segment by Type
1.2.2 Drug Eluting Stents (DES) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG ELUTING STENTS (DES) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drug Eluting Stents (DES) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drug Eluting Stents (DES) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG ELUTING STENTS (DES) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drug Eluting Stents (DES) Product Life Cycle
3.3 Global Drug Eluting Stents (DES) Sales by Manufacturers (2020-2025)
3.4 Global Drug Eluting Stents (DES) Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug Eluting Stents (DES) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Drug Eluting Stents (DES) Market Competitive Situation and Trends
3.8.1 Drug Eluting Stents (DES) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug Eluting Stents (DES) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUG ELUTING STENTS (DES) INDUSTRY CHAIN ANALYSIS
4.1 Drug Eluting Stents (DES) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG ELUTING STENTS (DES) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drug Eluting Stents (DES) Market
5.7 ESG Ratings of Leading Companies
6 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
6.3 Global Drug Eluting Stents (DES) Market Size by Type (2020-2025)
6.4 Global Drug Eluting Stents (DES) Price by Type (2020-2025)
7 DRUG ELUTING STENTS (DES) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Eluting Stents (DES) Market Sales by Application (2020-2025)
7.3 Global Drug Eluting Stents (DES) Market Size (M USD) by Application (2020-2025)
7.4 Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
8 DRUG ELUTING STENTS (DES) MARKET SALES BY REGION
8.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.1 Global Drug Eluting Stents (DES) Sales by Region
8.1.2 Global Drug Eluting Stents (DES) Sales Market Share by Region
8.2 Global Drug Eluting Stents (DES) Market Size by Region
8.2.1 Global Drug Eluting Stents (DES) Market Size by Region
8.2.2 Global Drug Eluting Stents (DES) Market Size by Region
8.3 North America
8.3.1 North America Drug Eluting Stents (DES) Sales by Country
8.3.2 North America Drug Eluting Stents (DES) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drug Eluting Stents (DES) Sales by Country
8.4.2 Europe Drug Eluting Stents (DES) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drug Eluting Stents (DES) Sales by Region
8.5.2 Asia Pacific Drug Eluting Stents (DES) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drug Eluting Stents (DES) Sales by Country
8.6.2 South America Drug Eluting Stents (DES) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drug Eluting Stents (DES) Sales by Region
8.7.2 Middle East and Africa Drug Eluting Stents (DES) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUG ELUTING STENTS (DES) MARKET PRODUCTION BY REGION
9.1 Global Production of Drug Eluting Stents (DES) by Region(2020-2025)
9.2 Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
9.3 Global Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drug Eluting Stents (DES) Production
9.4.1 North America Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.4.2 North America Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drug Eluting Stents (DES) Production
9.5.1 Europe Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.5.2 Europe Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drug Eluting Stents (DES) Production (2020-2025)
9.6.1 Japan Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.6.2 Japan Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drug Eluting Stents (DES) Production (2020-2025)
9.7.1 China Drug Eluting Stents (DES) Production Growth Rate (2020-2025)
9.7.2 China Drug Eluting Stents (DES) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Vascular
10.1.1 Abbott Vascular Basic Information
10.1.2 Abbott Vascular Drug Eluting Stents (DES) Product Overview
10.1.3 Abbott Vascular Drug Eluting Stents (DES) Product Market Performance
10.1.4 Abbott Vascular Business Overview
10.1.5 Abbott Vascular SWOT Analysis
10.1.6 Abbott Vascular Recent Developments
10.2 Advantec Vascular
10.2.1 Advantec Vascular Basic Information
10.2.2 Advantec Vascular Drug Eluting Stents (DES) Product Overview
10.2.3 Advantec Vascular Drug Eluting Stents (DES) Product Market Performance
10.2.4 Advantec Vascular Business Overview
10.2.5 Advantec Vascular SWOT Analysis
10.2.6 Advantec Vascular Recent Developments
10.3 B.Braun Melsengen AG
10.3.1 B.Braun Melsengen AG Basic Information
10.3.2 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Product Market Performance
10.3.4 B.Braun Melsengen AG Business Overview
10.3.5 B.Braun Melsengen AG SWOT Analysis
10.3.6 B.Braun Melsengen AG Recent Developments
10.4 Biosensors
10.4.1 Biosensors Basic Information
10.4.2 Biosensors Drug Eluting Stents (DES) Product Overview
10.4.3 Biosensors Drug Eluting Stents (DES) Product Market Performance
10.4.4 Biosensors Business Overview
10.4.5 Biosensors Recent Developments
10.5 Biotronik
10.5.1 Biotronik Basic Information
10.5.2 Biotronik Drug Eluting Stents (DES) Product Overview
10.5.3 Biotronik Drug Eluting Stents (DES) Product Market Performance
10.5.4 Biotronik Business Overview
10.5.5 Biotronik Recent Developments
10.6 Blue Medical
10.6.1 Blue Medical Basic Information
10.6.2 Blue Medical Drug Eluting Stents (DES) Product Overview
10.6.3 Blue Medical Drug Eluting Stents (DES) Product Market Performance
10.6.4 Blue Medical Business Overview
10.6.5 Blue Medical Recent Developments
10.7 Boston Scientific
10.7.1 Boston Scientific Basic Information
10.7.2 Boston Scientific Drug Eluting Stents (DES) Product Overview
10.7.3 Boston Scientific Drug Eluting Stents (DES) Product Market Performance
10.7.4 Boston Scientific Business Overview
10.7.5 Boston Scientific Recent Developments
10.8 DISA Vascular
10.8.1 DISA Vascular Basic Information
10.8.2 DISA Vascular Drug Eluting Stents (DES) Product Overview
10.8.3 DISA Vascular Drug Eluting Stents (DES) Product Market Performance
10.8.4 DISA Vascular Business Overview
10.8.5 DISA Vascular Recent Developments
10.9 Essen
10.9.1 Essen Basic Information
10.9.2 Essen Drug Eluting Stents (DES) Product Overview
10.9.3 Essen Drug Eluting Stents (DES) Product Market Performance
10.9.4 Essen Business Overview
10.9.5 Essen Recent Developments
10.10 Medtronic Vascular
10.10.1 Medtronic Vascular Basic Information
10.10.2 Medtronic Vascular Drug Eluting Stents (DES) Product Overview
10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Product Market Performance
10.10.4 Medtronic Vascular Business Overview
10.10.5 Medtronic Vascular Recent Developments
10.11 MicroPort Medical
10.11.1 MicroPort Medical Basic Information
10.11.2 MicroPort Medical Drug Eluting Stents (DES) Product Overview
10.11.3 MicroPort Medical Drug Eluting Stents (DES) Product Market Performance
10.11.4 MicroPort Medical Business Overview
10.11.5 MicroPort Medical Recent Developments
10.12 MIV Therapeutics
10.12.1 MIV Therapeutics Basic Information
10.12.2 MIV Therapeutics Drug Eluting Stents (DES) Product Overview
10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Product Market Performance
10.12.4 MIV Therapeutics Business Overview
10.12.5 MIV Therapeutics Recent Developments
10.13 Orbusneich
10.13.1 Orbusneich Basic Information
10.13.2 Orbusneich Drug Eluting Stents (DES) Product Overview
10.13.3 Orbusneich Drug Eluting Stents (DES) Product Market Performance
10.13.4 Orbusneich Business Overview
10.13.5 Orbusneich Recent Developments
10.14 Promed Medical
10.14.1 Promed Medical Basic Information
10.14.2 Promed Medical Drug Eluting Stents (DES) Product Overview
10.14.3 Promed Medical Drug Eluting Stents (DES) Product Market Performance
10.14.4 Promed Medical Business Overview
10.14.5 Promed Medical Recent Developments
10.15 Relisys Medical
10.15.1 Relisys Medical Basic Information
10.15.2 Relisys Medical Drug Eluting Stents (DES) Product Overview
10.15.3 Relisys Medical Drug Eluting Stents (DES) Product Market Performance
10.15.4 Relisys Medical Business Overview
10.15.5 Relisys Medical Recent Developments
10.16 Reva Medical
10.16.1 Reva Medical Basic Information
10.16.2 Reva Medical Drug Eluting Stents (DES) Product Overview
10.16.3 Reva Medical Drug Eluting Stents (DES) Product Market Performance
10.16.4 Reva Medical Business Overview
10.16.5 Reva Medical Recent Developments
10.17 Sahajanand
10.17.1 Sahajanand Basic Information
10.17.2 Sahajanand Drug Eluting Stents (DES) Product Overview
10.17.3 Sahajanand Drug Eluting Stents (DES) Product Market Performance
10.17.4 Sahajanand Business Overview
10.17.5 Sahajanand Recent Developments
10.18 Sino Medical
10.18.1 Sino Medical Basic Information
10.18.2 Sino Medical Drug Eluting Stents (DES) Product Overview
10.18.3 Sino Medical Drug Eluting Stents (DES) Product Market Performance
10.18.4 Sino Medical Business Overview
10.18.5 Sino Medical Recent Developments
10.19 Sorin
10.19.1 Sorin Basic Information
10.19.2 Sorin Drug Eluting Stents (DES) Product Overview
10.19.3 Sorin Drug Eluting Stents (DES) Product Market Performance
10.19.4 Sorin Business Overview
10.19.5 Sorin Recent Developments
10.20 Terumo Medical
10.20.1 Terumo Medical Basic Information
10.20.2 Terumo Medical Drug Eluting Stents (DES) Product Overview
10.20.3 Terumo Medical Drug Eluting Stents (DES) Product Market Performance
10.20.4 Terumo Medical Business Overview
10.20.5 Terumo Medical Recent Developments
11 DRUG ELUTING STENTS (DES) MARKET FORECAST BY REGION
11.1 Global Drug Eluting Stents (DES) Market Size Forecast
11.2 Global Drug Eluting Stents (DES) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.3 Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region
11.2.4 South America Drug Eluting Stents (DES) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drug Eluting Stents (DES) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drug Eluting Stents (DES) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drug Eluting Stents (DES) by Type (2026-2035)
12.1.2 Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drug Eluting Stents (DES) by Type (2026-2035)
12.2 Global Drug Eluting Stents (DES) Market Forecast by Application (2026-2035)
12.2.1 Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application
12.2.2 Global Drug Eluting Stents (DES) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 4. Global Drug Eluting Stents (DES) Market Size by Application
Table 5. Drug Eluting Stents (DES) Market Size Comparison by Region (M USD)
Table 6. Global Drug Eluting Stents (DES) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug Eluting Stents (DES) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2025)
Table 11. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Drug Eluting Stents (DES) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug Eluting Stents (DES) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drug Eluting Stents (DES) Sales by Type (K Units)
Table 27. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 28. Global Drug Eluting Stents (DES) Sales (K Units) by Type (2020-2025)
Table 29. Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
Table 30. Global Drug Eluting Stents (DES) Market Size (M USD) by Type (2020-2025)
Table 31. Global Drug Eluting Stents (DES) Market Share by Type (2020-2025)
Table 32. Global Drug Eluting Stents (DES) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Drug Eluting Stents (DES) Sales (K Units) by Application
Table 34. Global Drug Eluting Stents (DES) Market Size by Application
Table 35. Global Drug Eluting Stents (DES) Sales by Application (2020-2025) & (K Units)
Table 36. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Table 37. Global Drug Eluting Stents (DES) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Table 39. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Table 40. Global Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 41. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Table 42. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025)
Table 44. North America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 45. North America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 51. South America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drug Eluting Stents (DES) Production (K Units) by Region(2020-2025)
Table 55. Global Drug Eluting Stents (DES) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
Table 57. Global Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Vascular Basic Information
Table 63. Abbott Vascular Drug Eluting Stents (DES) Product Overview
Table 64. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Vascular Business Overview
Table 66. Abbott Vascular SWOT Analysis
Table 67. Abbott Vascular Recent Developments
Table 68. Advantec Vascular Basic Information
Table 69. Advantec Vascular Drug Eluting Stents (DES) Product Overview
Table 70. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Advantec Vascular Business Overview
Table 72. Advantec Vascular SWOT Analysis
Table 73. Advantec Vascular Recent Developments
Table 74. B.Braun Melsengen AG Basic Information
Table 75. B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
Table 76. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. B.Braun Melsengen AG Business Overview
Table 78. B.Braun Melsengen AG SWOT Analysis
Table 79. B.Braun Melsengen AG Recent Developments
Table 80. Biosensors Basic Information
Table 81. Biosensors Drug Eluting Stents (DES) Product Overview
Table 82. Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biosensors Business Overview
Table 84. Biosensors Recent Developments
Table 85. Biotronik Basic Information
Table 86. Biotronik Drug Eluting Stents (DES) Product Overview
Table 87. Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biotronik Business Overview
Table 89. Biotronik Recent Developments
Table 90. Blue Medical Basic Information
Table 91. Blue Medical Drug Eluting Stents (DES) Product Overview
Table 92. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Blue Medical Business Overview
Table 94. Blue Medical Recent Developments
Table 95. Boston Scientific Basic Information
Table 96. Boston Scientific Drug Eluting Stents (DES) Product Overview
Table 97. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Boston Scientific Business Overview
Table 99. Boston Scientific Recent Developments
Table 100. DISA Vascular Basic Information
Table 101. DISA Vascular Drug Eluting Stents (DES) Product Overview
Table 102. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. DISA Vascular Business Overview
Table 104. DISA Vascular Recent Developments
Table 105. Essen Basic Information
Table 106. Essen Drug Eluting Stents (DES) Product Overview
Table 107. Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Essen Business Overview
Table 109. Essen Recent Developments
Table 110. Medtronic Vascular Basic Information
Table 111. Medtronic Vascular Drug Eluting Stents (DES) Product Overview
Table 112. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Medtronic Vascular Business Overview
Table 114. Medtronic Vascular Recent Developments
Table 115. MicroPort Medical Basic Information
Table 116. MicroPort Medical Drug Eluting Stents (DES) Product Overview
Table 117. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. MicroPort Medical Business Overview
Table 119. MicroPort Medical Recent Developments
Table 120. MIV Therapeutics Basic Information
Table 121. MIV Therapeutics Drug Eluting Stents (DES) Product Overview
Table 122. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. MIV Therapeutics Business Overview
Table 124. MIV Therapeutics Recent Developments
Table 125. Orbusneich Basic Information
Table 126. Orbusneich Drug Eluting Stents (DES) Product Overview
Table 127. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Orbusneich Business Overview
Table 129. Orbusneich Recent Developments
Table 130. Promed Medical Basic Information
Table 131. Promed Medical Drug Eluting Stents (DES) Product Overview
Table 132. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Promed Medical Business Overview
Table 134. Promed Medical Recent Developments
Table 135. Relisys Medical Basic Information
Table 136. Relisys Medical Drug Eluting Stents (DES) Product Overview
Table 137. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Relisys Medical Business Overview
Table 139. Relisys Medical Recent Developments
Table 140. Reva Medical Basic Information
Table 141. Reva Medical Drug Eluting Stents (DES) Product Overview
Table 142. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Reva Medical Business Overview
Table 144. Reva Medical Recent Developments
Table 145. Sahajanand Basic Information
Table 146. Sahajanand Drug Eluting Stents (DES) Product Overview
Table 147. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Sahajanand Business Overview
Table 149. Sahajanand Recent Developments
Table 150. Sino Medical Basic Information
Table 151. Sino Medical Drug Eluting Stents (DES) Product Overview
Table 152. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Sino Medical Business Overview
Table 154. Sino Medical Recent Developments
Table 155. Sorin Basic Information
Table 156. Sorin Drug Eluting Stents (DES) Product Overview
Table 157. Sorin Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sorin Business Overview
Table 159. Sorin Recent Developments
Table 160. Terumo Medical Basic Information
Table 161. Terumo Medical Drug Eluting Stents (DES) Product Overview
Table 162. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Terumo Medical Business Overview
Table 164. Terumo Medical Recent Developments
Table 165. Global Drug Eluting Stents (DES) Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Drug Eluting Stents (DES) Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Drug Eluting Stents (DES) Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Drug Eluting Stents (DES) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global Drug Eluting Stents (DES) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 4. Global Drug Eluting Stents (DES) Market Size by Application
Table 5. Drug Eluting Stents (DES) Market Size Comparison by Region (M USD)
Table 6. Global Drug Eluting Stents (DES) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Drug Eluting Stents (DES) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug Eluting Stents (DES) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2025)
Table 11. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Drug Eluting Stents (DES) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drug Eluting Stents (DES) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drug Eluting Stents (DES) Sales by Type (K Units)
Table 27. Global Drug Eluting Stents (DES) Market Size by Type (M USD)
Table 28. Global Drug Eluting Stents (DES) Sales (K Units) by Type (2020-2025)
Table 29. Global Drug Eluting Stents (DES) Sales Market Share by Type (2020-2025)
Table 30. Global Drug Eluting Stents (DES) Market Size (M USD) by Type (2020-2025)
Table 31. Global Drug Eluting Stents (DES) Market Share by Type (2020-2025)
Table 32. Global Drug Eluting Stents (DES) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Drug Eluting Stents (DES) Sales (K Units) by Application
Table 34. Global Drug Eluting Stents (DES) Market Size by Application
Table 35. Global Drug Eluting Stents (DES) Sales by Application (2020-2025) & (K Units)
Table 36. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Table 37. Global Drug Eluting Stents (DES) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Table 39. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Table 40. Global Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 41. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Table 42. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025)
Table 44. North America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 45. North America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drug Eluting Stents (DES) Sales by Country (2020-2025) & (K Units)
Table 51. South America Drug Eluting Stents (DES) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drug Eluting Stents (DES) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Drug Eluting Stents (DES) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drug Eluting Stents (DES) Production (K Units) by Region(2020-2025)
Table 55. Global Drug Eluting Stents (DES) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drug Eluting Stents (DES) Revenue Market Share by Region (2020-2025)
Table 57. Global Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Drug Eluting Stents (DES) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Vascular Basic Information
Table 63. Abbott Vascular Drug Eluting Stents (DES) Product Overview
Table 64. Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Vascular Business Overview
Table 66. Abbott Vascular SWOT Analysis
Table 67. Abbott Vascular Recent Developments
Table 68. Advantec Vascular Basic Information
Table 69. Advantec Vascular Drug Eluting Stents (DES) Product Overview
Table 70. Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Advantec Vascular Business Overview
Table 72. Advantec Vascular SWOT Analysis
Table 73. Advantec Vascular Recent Developments
Table 74. B.Braun Melsengen AG Basic Information
Table 75. B.Braun Melsengen AG Drug Eluting Stents (DES) Product Overview
Table 76. B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. B.Braun Melsengen AG Business Overview
Table 78. B.Braun Melsengen AG SWOT Analysis
Table 79. B.Braun Melsengen AG Recent Developments
Table 80. Biosensors Basic Information
Table 81. Biosensors Drug Eluting Stents (DES) Product Overview
Table 82. Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biosensors Business Overview
Table 84. Biosensors Recent Developments
Table 85. Biotronik Basic Information
Table 86. Biotronik Drug Eluting Stents (DES) Product Overview
Table 87. Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Biotronik Business Overview
Table 89. Biotronik Recent Developments
Table 90. Blue Medical Basic Information
Table 91. Blue Medical Drug Eluting Stents (DES) Product Overview
Table 92. Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Blue Medical Business Overview
Table 94. Blue Medical Recent Developments
Table 95. Boston Scientific Basic Information
Table 96. Boston Scientific Drug Eluting Stents (DES) Product Overview
Table 97. Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Boston Scientific Business Overview
Table 99. Boston Scientific Recent Developments
Table 100. DISA Vascular Basic Information
Table 101. DISA Vascular Drug Eluting Stents (DES) Product Overview
Table 102. DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. DISA Vascular Business Overview
Table 104. DISA Vascular Recent Developments
Table 105. Essen Basic Information
Table 106. Essen Drug Eluting Stents (DES) Product Overview
Table 107. Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Essen Business Overview
Table 109. Essen Recent Developments
Table 110. Medtronic Vascular Basic Information
Table 111. Medtronic Vascular Drug Eluting Stents (DES) Product Overview
Table 112. Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Medtronic Vascular Business Overview
Table 114. Medtronic Vascular Recent Developments
Table 115. MicroPort Medical Basic Information
Table 116. MicroPort Medical Drug Eluting Stents (DES) Product Overview
Table 117. MicroPort Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. MicroPort Medical Business Overview
Table 119. MicroPort Medical Recent Developments
Table 120. MIV Therapeutics Basic Information
Table 121. MIV Therapeutics Drug Eluting Stents (DES) Product Overview
Table 122. MIV Therapeutics Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. MIV Therapeutics Business Overview
Table 124. MIV Therapeutics Recent Developments
Table 125. Orbusneich Basic Information
Table 126. Orbusneich Drug Eluting Stents (DES) Product Overview
Table 127. Orbusneich Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Orbusneich Business Overview
Table 129. Orbusneich Recent Developments
Table 130. Promed Medical Basic Information
Table 131. Promed Medical Drug Eluting Stents (DES) Product Overview
Table 132. Promed Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Promed Medical Business Overview
Table 134. Promed Medical Recent Developments
Table 135. Relisys Medical Basic Information
Table 136. Relisys Medical Drug Eluting Stents (DES) Product Overview
Table 137. Relisys Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Relisys Medical Business Overview
Table 139. Relisys Medical Recent Developments
Table 140. Reva Medical Basic Information
Table 141. Reva Medical Drug Eluting Stents (DES) Product Overview
Table 142. Reva Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Reva Medical Business Overview
Table 144. Reva Medical Recent Developments
Table 145. Sahajanand Basic Information
Table 146. Sahajanand Drug Eluting Stents (DES) Product Overview
Table 147. Sahajanand Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Sahajanand Business Overview
Table 149. Sahajanand Recent Developments
Table 150. Sino Medical Basic Information
Table 151. Sino Medical Drug Eluting Stents (DES) Product Overview
Table 152. Sino Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Sino Medical Business Overview
Table 154. Sino Medical Recent Developments
Table 155. Sorin Basic Information
Table 156. Sorin Drug Eluting Stents (DES) Product Overview
Table 157. Sorin Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Sorin Business Overview
Table 159. Sorin Recent Developments
Table 160. Terumo Medical Basic Information
Table 161. Terumo Medical Drug Eluting Stents (DES) Product Overview
Table 162. Terumo Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Terumo Medical Business Overview
Table 164. Terumo Medical Recent Developments
Table 165. Global Drug Eluting Stents (DES) Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Drug Eluting Stents (DES) Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific Drug Eluting Stents (DES) Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Drug Eluting Stents (DES) Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Drug Eluting Stents (DES) Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Drug Eluting Stents (DES) Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global Drug Eluting Stents (DES) Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Drug Eluting Stents (DES) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global Drug Eluting Stents (DES) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drug Eluting Stents (DES)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Eluting Stents (DES) Market Size (M USD), 2025-2035
Figure 5. Global Drug Eluting Stents (DES) Market Size (M USD) (2020-2035)
Figure 6. Global Drug Eluting Stents (DES) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Eluting Stents (DES) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug Eluting Stents (DES) Product Life Cycle
Figure 13. Drug Eluting Stents (DES) Sales Share by Manufacturers in 2025
Figure 14. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers in 2025
Figure 15. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug Eluting Stents (DES) Revenue in 2025
Figure 18. Industry Chain Map of Drug Eluting Stents (DES)
Figure 19. Global Drug Eluting Stents (DES) Market PEST Analysis
Figure 20. Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug Eluting Stents (DES) Market Share by Type
Figure 27. Sales Market Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 28. Sales Market Share of Drug Eluting Stents (DES) by Type in 2025
Figure 29. Market Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 30. Market Share of Drug Eluting Stents (DES) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug Eluting Stents (DES) Market Share by Application
Figure 33. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Figure 34. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2025
Figure 35. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Figure 36. Global Drug Eluting Stents (DES) Market Share by Application in 2025
Figure 37. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Figure 39. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025)
Figure 40. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 43. North America Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 45. U.S. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Drug Eluting Stents (DES) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug Eluting Stents (DES) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug Eluting Stents (DES) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 53. Europe Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 55. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug Eluting Stents (DES) Market Size by Region in 2024
Figure 68. China Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 79. South America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 80. South America Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 81. South America Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 82. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug Eluting Stents (DES) Market Size by Region in 2024
Figure 92. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug Eluting Stents (DES) Production Market Share by Region (2020-2025)
Figure 103. North America Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Drug Eluting Stents (DES) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Drug Eluting Stents (DES) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2026-2035)
Figure 111. Global Drug Eluting Stents (DES) Sales Forecast by Application (2026-2035)
Figure 112. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Drug Eluting Stents (DES)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Eluting Stents (DES) Market Size (M USD), 2025-2035
Figure 5. Global Drug Eluting Stents (DES) Market Size (M USD) (2020-2035)
Figure 6. Global Drug Eluting Stents (DES) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug Eluting Stents (DES) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug Eluting Stents (DES) Product Life Cycle
Figure 13. Drug Eluting Stents (DES) Sales Share by Manufacturers in 2025
Figure 14. Global Drug Eluting Stents (DES) Revenue Share by Manufacturers in 2025
Figure 15. Drug Eluting Stents (DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drug Eluting Stents (DES) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug Eluting Stents (DES) Revenue in 2025
Figure 18. Industry Chain Map of Drug Eluting Stents (DES)
Figure 19. Global Drug Eluting Stents (DES) Market PEST Analysis
Figure 20. Global Drug Eluting Stents (DES) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drug Eluting Stents (DES) Market Share by Type
Figure 27. Sales Market Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 28. Sales Market Share of Drug Eluting Stents (DES) by Type in 2025
Figure 29. Market Share of Drug Eluting Stents (DES) by Type (2020-2025)
Figure 30. Market Share of Drug Eluting Stents (DES) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drug Eluting Stents (DES) Market Share by Application
Figure 33. Global Drug Eluting Stents (DES) Sales Market Share by Application (2020-2025)
Figure 34. Global Drug Eluting Stents (DES) Sales Market Share by Application in 2025
Figure 35. Global Drug Eluting Stents (DES) Market Share by Application (2020-2025)
Figure 36. Global Drug Eluting Stents (DES) Market Share by Application in 2025
Figure 37. Global Drug Eluting Stents (DES) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drug Eluting Stents (DES) Sales Market Share by Region (2020-2025)
Figure 39. Global Drug Eluting Stents (DES) Market Size by Region (2020-2025)
Figure 40. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 43. North America Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 45. U.S. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Drug Eluting Stents (DES) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drug Eluting Stents (DES) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drug Eluting Stents (DES) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 53. Europe Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 55. Germany Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drug Eluting Stents (DES) Market Size by Region in 2024
Figure 68. China Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 79. South America Drug Eluting Stents (DES) Sales Market Share by Country in 2024
Figure 80. South America Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 81. South America Drug Eluting Stents (DES) Market Size by Country in 2024
Figure 82. Brazil Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drug Eluting Stents (DES) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Drug Eluting Stents (DES) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drug Eluting Stents (DES) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drug Eluting Stents (DES) Market Size by Region in 2024
Figure 92. Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Drug Eluting Stents (DES) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drug Eluting Stents (DES) Production Market Share by Region (2020-2025)
Figure 103. North America Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Drug Eluting Stents (DES) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Drug Eluting Stents (DES) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Drug Eluting Stents (DES) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drug Eluting Stents (DES) Market Share Forecast by Type (2026-2035)
Figure 111. Global Drug Eluting Stents (DES) Sales Forecast by Application (2026-2035)
Figure 112. Global Drug Eluting Stents (DES) Market Share Forecast by Application (2026-2035)
